{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:23:00Z","timestamp":1790518980805,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":1613,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1074\/jbc.m115.688168","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T03:34:37Z","timestamp":1456198477000},"page":"9638-9647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages"],"prefix":"10.1016","volume":"291","author":[{"given":"Luuk C.T.","family":"Dohmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deninson Alejandro","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Kip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.C.","family":"Dorlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaida","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.688168_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.688168_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1586\/14787210.2014.916614","article-title":"Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?","volume":"12","author":"Vanaerschot","year":"2014","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1074\/jbc.M115.688168_bib3","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1074\/jbc.M115.688168_bib4","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1074\/jbc.M115.688168_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1074\/jbc.M115.688168_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children","volume":"205","author":"Rubiano","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1074\/jbc.M115.688168_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Tropica"},{"key":"10.1074\/jbc.M115.688168_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1074\/jbc.M115.688168_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"Fern\u00e1ndez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1074\/jbc.M115.688168_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1074\/jbc.M115.688168_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"Dorlo","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1074\/jbc.M115.688168_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/dkt334","article-title":"Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival","volume":"69","author":"G\u00f3mez","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1074\/jbc.M115.688168_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection","volume":"52","author":"Mookerjee Basu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.M115.688168_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2015.06.017","article-title":"Quantification of miltefosine in peripheral blood mononuclear cells by high-performance liquid chromatography-tandem mass spectrometry","volume":"998\u2013999","author":"Kip","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1074\/jbc.M115.688168_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11745-007-3026-8","article-title":"Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process","volume":"42","author":"M\u00e9nez","year":"2007","journal-title":"Lipids"},{"key":"10.1074\/jbc.M115.688168_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11095-006-9170-7","article-title":"Intestinal absorption of miltefosine: contribution of passive paracellular transport","volume":"24","author":"M\u00e9nez","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1074\/jbc.M115.688168_bib17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1054\/bjoc.2001.1776","article-title":"MDR1 causes resistance to the antitumour drug miltefosine","volume":"84","author":"Rybczynska","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M115.688168_bib18","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"P\u00e9rez-Victoria","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.M115.688168_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389450023347588","article-title":"Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents","volume":"3","author":"P\u00e9rez-Victoria","year":"2002","journal-title":"Curr. Drug Targets"},{"key":"10.1074\/jbc.M115.688168_bib20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-2958.2007.05653.x","article-title":"A novel ATP-binding cassette transporter from Leishmania is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids","volume":"64","author":"Castanys-Mu\u00f1oz","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1074\/jbc.M115.688168_bib21","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"Castanys-Mu\u00f1oz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.M115.688168_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.01023-13","article-title":"Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species","volume":"58","author":"Obonaga","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.M115.688168_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models","volume":"110","author":"Roy","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1074\/jbc.M115.688168_bib24","article-title":"Genome-wide RNAi screen in IFN-\u03b3-treated human macrophages identifies genes mediating resistance to the intracellular pathogen Francisella tularensis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.688168_bib25","first-page":"613","article-title":"Tests for departure from normality: empirical results for the distributions of b2 and b1","volume":"60","author":"D'Agostino","year":"1973","journal-title":"Biometrika"},{"key":"10.1074\/jbc.M115.688168_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tem.2013.01.006","article-title":"Role of ABC transporters in lipid transport and human disease","volume":"24","author":"Tarling","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1074\/jbc.M115.688168_bib27","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.febslet.2007.05.078","article-title":"ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells","volume":"581","author":"Matsumura","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.M115.688168_bib28","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1074\/jbc.M507515200","article-title":"Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome","volume":"281","author":"Cheong","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M115.688168_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jac\/dkp500","article-title":"In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent","volume":"65","author":"Seifert","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1074\/jbc.M115.688168_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/msb.2011.47","article-title":"A pharmacogenomic method for individualized prediction of drug sensitivity","volume":"7","author":"Cohen","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1074\/jbc.M115.688168_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-59745-205-2_5","article-title":"Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy","volume":"448","author":"Bosch","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1074\/jbc.M115.688168_bib32","doi-asserted-by":"crossref","first-page":"23811","DOI":"10.1074\/jbc.M703927200","article-title":"ABCA3 is critical for lamellar body biogenesis in vivo","volume":"282","author":"Cheong","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M115.688168_bib33","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2008.103","article-title":"Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration","volume":"22","author":"Chapuy","year":"2008","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.688168_bib34","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1074\/jbc.M611767200","article-title":"ABCA3 as a lipid transporter in pulmonary surfactant biogenesis","volume":"282","author":"Ban","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M115.688168_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/pr.2012.21","article-title":"An intronic ABCA3 mutation that is responsible for respiratory disease","volume":"71","author":"Agrawal","year":"2012","journal-title":"Pediat. Res."},{"key":"10.1074\/jbc.M115.688168_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000348884","article-title":"Intracellular ATP-binding cassette transporter A3 is expressed in lung cancer cells and modulates susceptibility to cisplatin and paclitaxel","volume":"84","author":"Overbeck","year":"2013","journal-title":"Oncology"},{"key":"10.1074\/jbc.M115.688168_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0092-8674(00)81201-5","article-title":"The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.688168_bib38","first-page":"931","article-title":"Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin","volume":"32","author":"Song","year":"2008","journal-title":"Int. J. Oncol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820431035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820431035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.688168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:25:43Z","timestamp":1641299143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820431035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0021925820431035"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.688168","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.688168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}